Latest filing published 23 May 2022 for 信邦制药.
高文林: trading record in brief
高文林, listed as senior executive, appears in our data through filings on 信邦制药 shares, published by SSE / SZSE (CSRC). We count 2 filings; the first trade dates from 20 May 2022 and the latest from 23 May 2022.
The open-market record is one-sided, with 2 purchases worth €141k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 23 May 2022 with an open-market purchase (€70k) in 信邦制药. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 高文林
Open company profiles for insider transactions, fundamentals and analyst consensus when available.